Naloxegol for treating opioid‑induced constipation

Constipation (opioid-induced) - naloxegol: equality impact assessment - guidance development

Constipation (opioid-induced) - naloxegol: final appraisal determination information

Constipation (opioid-induced) - naloxegol: final appraisal determination document

Constipation (opioid-induced) - naloxegol: final appraisal determination document (PDF 163 KB)

Constipation (opioid-induced) - naloxegol: committee papers information

Constipation (opioid-induced) - naloxegol: final scope 

Constipation (opioid induced) - naloxegol: final matrix

Constipation (opioid induced) - naloxegol: equality impact assessment - scoping

Constipation (opioid induced) - naloxegol: NICE's response to C&C comments on the draft scope and provisional matrix

Constipation (opioid-induced) - naloxegol: draft scope for consultation (pre-referral) - September 2013 

Constipation (opioid-induced) - naloxegol: provisional matrix (pre-referral) - September 2013